Found 6 matching trials
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients PHASE2 This is a phase 2, randomized, placebo controlled, multi-center study to es...
Show More Learn More & Join Trial
Amgen 386 for Recurrent Glioblastoma PHASE1 Primary Objectives
Cohort A -- monotherapy:
To determine the efficacy of ...
Show More Location
University of California Los Angeles
Learn More & Join Trial
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. PHASE1 The purpose of this study is to evaluate the safety, tolerability and pharm...
Show More Location
Multiple Locations
Learn More & Join Trial
Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer PHASE2 This is a clinical trial investigating the effectiveness and safety of the ...
Show More Learn More & Join Trial
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors PHASE2 This partially randomized phase II trial with a safety run-in component stu...
Show More Location
Alaska Breast Care and Surgery LLC
Learn More & Join Trial
Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer PHASE2 This randomized phase II trial studies how well trebananib with or without ...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial